Combining Targeted Therapies: Practical Issues to Consider at the Bench and Bedside

Por Rodon, Jordi, Perez, Jose, Kurzrock, Razelle
Publicado em 2010

Pilot Studies for Personalized Cancer Medicine: Focusing on the Patient for Treatment Selection

Por De Mattos-Arruda, Leticia, Rodon, Jordi
Publicado em 2013

Toxicity as a Biomarker of Efficacy of Molecular Targeted Therapies: Focus on EGFR and VEGF Inhibiting Anticancer Drugs

Por Dienstmann, Rodrigo, Braña, Irene, Rodon, Jordi, Tabernero, Josep
Publicado em 2011

Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: Lessons from the first clinical trials

Por Rodon, Jordi, DeSantos, Victoria, Ferry, Robert Jean, Kurzrock, Razelle
Publicado em 2008

Unveiling changes in the landscape of patient populations in cancer early drug development

Por Hierro, Cinta, Azaro, Analía, Argilés, Guillem, Elez, Elena, Gómez, Patricia, Carles, Joan, Rodon, Jordi
Publicado no Oncotarget (2016)

Cryptogenic Stroke And Role Of Loop Recorder

Por PérezRodon, Jordi, FranciscoPascual, Jaume, RivasGándara, Nuria, RocaLuque, Ivo, Bellera, Neus, MoyaMitjans, Àngel
Publicado no J Atr Fibrillation (2014)

Trends in the use of electrical cardioversion for atrial fibrillation: influence of major trials and guidelines on clinical practice

Por Alegret, Josep M, Viñolas, Xavier, Romero-Menor, César, Pons, Silvia, Villuendas, Roger, Calvo, Naiara, Pérez-Rodon, Jordi, Sabaté, Xavier
Publicado em 2012

R1507, an Anti-Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antibody, and EWS/FLI-1 siRNA in Ewing's Sarcoma: Convergence at the IGF/IGFR/Akt Axis

Por Huang, Helen J., Angelo, Laura S., Rodon, Jordi, Sun, Michael, Kuenkele, Klaus-Peter, Parsons, Henrique A., Trent, Jonathan C., Kurzrock, Razelle
Publicado em 2011

A framework for genomic biomarker actionability and its use in clinical decision making

Por Vidwans, Smruti J., Turski, Michelle L., Janku, Filip, Garrido-Laguna, Ignacio, Munoz, Javier, Schwab, Richard, Subbiah, Vivek, Rodon, Jordi, Kurzrock, Razelle
Publicado no Oncoscience (2014)

Other targeted drugs in melanoma

Por González-Cao, María, Rodón, Jordi, Karachaliou, Niki, Sánchez, Jesús, Santarpia, Mariacarmela, Viteri, Santiago, Pilotto, Sara, Teixidó, Cristina, Riso, Aldo, Rosell, Rafael
Publicado no Ann Transl Med (2015)

Defining a therapeutic window for the novel TGF-β inhibitor LY2157299 monohydrate based on a pharmacokinetic/pharmacodynamic model

Por Gueorguieva, Ivelina, Cleverly, Ann L, Stauber, Anja, Pillay, N Sada, Rodon, Jordi A, Miles, Colin P, Yingling, Jonathan M, Lahn, Michael M
Publicado em 2014

Phase I Study of Sunitinib in Combination With Gemcitabine and Capecitabine for First-Line Treatment of Metastatic or Unresectable Renal Cell Carcinoma

Por Bellmunt, Joaquim, Suarez, Cristina, Gallardo, Enrique, Rodon, Jordi, Pons, Francesc, Bonfill, Teresa, Beltran, Marta, Moya, Irene, Galtes, Susana, Albanell, Joan, Carles, Joan
Publicado em 2014

Brain perfusion and permeability in patients with advanced, refractory glioblastoma treated with lomustine and the transforming growth factor-β receptor I kinase inhibitor LY215729...

Por SEPULVEDA-SANCHEZ, JUAN, RAMOS, ANA, HILARIO, AMAYA, DE VELASCO, GUILLERMO, CASTELLANO, DANIEL, GARCIA DE LA TORRE, MARTA, RODON, JORDI, LAHN, MICHAEL F.
Publicado no Oncol Lett (2015)

Relative bioavailability of three formulations of galunisertib administered as monotherapy in patients with advanced or metastatic cancer

Por Gueorguieva, Ivelina, Cleverly, Ann, Desaiah, Durisala, Azaro, Analia, Seoane, Joan, Braña, Irene, Sicart, Elisabet, Miles, Colin, Lahn, Michael M, Mitchell, Malcolm I, Rodon, Jordi
Publicado no Drugs Context (2016)

Life‐threatening and life‐saving inappropriate implantable cardioverter defibrillator shocks

Por Pérez‐Rodon, Jordi, Doiny, David, Miranda, Berta, Rivas‐Gandara, Nuria, Roca‐Luque, Ivo, Francisco‐Pascual, Jaume, Lidón, Rosa Maria, García‐Dorado, David, Moya Mitjans, Angel
Publicado no Clin Case Rep (2017)

ATNT-12 PHASE I, TWO-STAGE, OPEN-LABEL, DOSE-ESCALATION STUDY OF BUPARLISIB (BKM120) IN COMBINATION WITH ADJUVANT TEMOZOLOMIDE (TMZ) AND WITH CONCOMITANT RADIATION THERAPY (RT) AND...

Por Rodon, Jordi, Rosenthal, Mark, Mason, Warren, Segura, Pedro Perez, Beck, Joseph T., Hirte, Holger, DeGroot, John F., Trandafir, Lucia, Pognan, Nathalie, Yang, Lin, Kanwal, Charu, Wen, Patrick Y.
Publicado no Neuro Oncol (2015)

A phase I pharmacokinetic and safety study of cabazitaxel in adult cancer patients with normal and impaired renal function

Por Azaro, Analía, Rodón, Jordi, Machiels, Jean-Pascal, Rottey, Sylvie, Damian, Silvia, Baird, Richard, Garcia-Corbacho, Javier, Mathijssen, Ron H. J., Clot, Pierre-François, Wack, Claudine, Shen, Liji, de Jonge, Maja J. A.
Publicado no Cancer Chemother Pharmacol (2016)

Single Intracoronary Injection of Encapsulated Antagomir‐92a Promotes Angiogenesis and Prevents Adverse Infarct Remodeling

Por Bellera, Neus, Barba, Ignasi, Rodriguez‐Sinovas, Antonio, Ferret, Eulalia, Asín, Miguel Angel, Gonzalez‐Alujas, MªTeresa, Pérez‐Rodon, Jordi, Esteves, Marielle, Fonseca, Carla, Toran, Nuria, Garcia del Blanco, Bruno, Pérez, Amadeo, Garcia‐Dorado, David
Publicado no J Am Heart Assoc (2014)

ERRATUM: Genomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular Entity

Por Prat, Aleix, Adamo, Barbara, Fan, Cheng, Peg, Vicente, Vidal, Maria, Galván, Patricia, Vivancos, Ana, Nuciforo, Paolo, Palmer, Héctor G., Dawood, Shaheenah, Rodón, Jordi, Cajal, Santiago Ramon y, Campo, Josep Maria Del, Felip, Enriqueta, Tabernero, Josep, Cortés, Javier
Publicado no Sci Rep (2015)

Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced canc...

Por Rodón, Jordi, Carducci, Michael, Sepulveda-Sánchez, Juan M., Azaro, Analía, Calvo, Emiliano, Seoane, Joan, Braña, Irene, Sicart, Elisabet, Gueorguieva, Ivelina, Cleverly, Ann, Pillay, N. Sokalingum, Desaiah, Durisala, Estrem, Shawn T., Paz-Ares, Luis, Holdhoff, Matthias, Blakeley, Jaishri, Lahn, Michael M., Baselga, Jose
Publicado no Invest New Drugs (2014)